Call Us08045479576
Terbutaline Sulfate

Terbutaline Sulfate

25.00 - 50.00 INR/Kilograms

Product Details:

  • Molecular Weight 287.213 Grams (g)
  • Molecular Formula C9H14N5O4P
  • Storage Room Temperature
  • Medicine Name Terbutaline Sulfate
  • Type Pharmaceutical Intermediates
  • Grade Medicine Grade
  • Purity(%) 98%
  • Click to View more
X

Terbutaline Sulfate Price And Quantity

  • 25 Kilograms
  • 25.00 - 50.00 INR/Kilograms

Terbutaline Sulfate Product Specifications

  • Pharmaceutical Intermediates
  • 287.213 Grams (g)
  • Terbutaline Sulfate
  • Room Temperature
  • C9H14N5O4P
  • Powder
  • Medicine Grade
  • 98%

Terbutaline Sulfate Trade Information

  • Cash Advance (CA) Cash in Advance (CID)
  • 1000 Kilograms Per Day
  • 7 Days
  • Africa Western Europe Central America Eastern Europe Australia Middle East South America Asia North America

Product Description

It is a stypic or hemostatic agent that causes agglutination of surface proteins resulting in local hemostasis. In this domain, we are identified as one of the leading organizations, engaged in offering Terbutaline Sulfate. At our sophisticated processing unit, we process this drug using high quality compounds. This compound is used in fertilizer to control a variety of slugs and snails on a wide range of foods and ornamental crops. It is used as base coating for paint in order to increase adhesion to the iron or steel substrate. It can also be used for bonding fabrics, wood, and other materials to these surfaces as well.

Among other things, terbutaline, sold under the brand names Bricanyl and Marex, acts as a 2 adrenergic receptor agonist, disabling asthma symptoms and delaying preterm labor for up to 48 hours.

Terbutaline Sulfate Properties:

  • CAS Number: 23031-32-5
  • Formula: 2(C12H19NO3).H2SO4
  • Molecular Weight: 512.68
  • Deleted CAS: 98225-49-1 
  • Synonyms: 5-[1-hydroxy-2-(tert-butylamino)ethyl]benzene-1,3-diol;Bricanyl;Brethine;KWD 2019;Prestwick_598;Terbutalina [DCIT];Terbutalino [INN-Spanish];1,3-Benzenediol, 5-(2-((1,1-dimethylethyl)amino)-1-hydroxyethyl)- (9CI); Terbutalinum [INN-Latin]; Terbutaline sulfate (JP14/USP);1,3-Benzenediol,5-[2-[(1,1-dimethylethyl)- amino]-1-hydroxyethyl]-,sulfate (2: 1) (salt);5-[1-hydroxy-2-(tert-butylamino)ethyl]benzene-1,3-diol; sulfuric acid;Terbutaline Sulphate;Terbutaline hemisulfate salt;Terbutaline Sulphate IP/EP/USP; Benzyl alcohol, alpha-((t-butylamino)methyl)-3,5-dihydroxy-;Brethine (TN);
  • EINECS: 245-386-3
  • Melting Point: 246-248C
  • Boiling Point: 419.2 C at 760 mmHg
  • Flash Point: 165.3 C
  • Appearance: Crystalline Powder
  • Risk Codes: 42/43-63
  • Safety:    26-36

How does it work?

Among its uses are treating asthma, chronic bronchitis, and emphysema, as well as preventing and treating wheezing, shortness of breath, and chest tightness. Terbutaline belongs to a class of medications called beta agonists. The effect is to relax and open the airways, making breathing easier.

How to use:

Take this medication by mouth with or without food, usually three times per day or as directed by your doctor. There are several dosage options depending on your health and response to treatment. For adults and children older than 15, the recommended daily dose is 15 milligrams.

Dosage of usage:

It is only recommended to administer subcutaneously and not intravenously. When doses and administration are not followed correctly, accurate dosing and sterility cannot be guaranteed.

Side effects:

The adverse reactions seen with Terbutaline are similar to those experienced with other sympathomimetic agents. All of them are temporary and rarely require treatment.

Warnings and precautions while using this product:

Deterioration of Asthma

When asthma worsens, it may happen suddenly over a few hours or it may happen over several days or longer. When a patient requires more terbutaline sulfate than usual, it may be an indication of asthma instability, and the patient and treatment regimen should be re-evaluated, taking into account potential anti-inflammatory treatment needs, such as corticosteroids.

Cardiovascular Effects

Patients with terbutaline sulfate may experience a clinically significant cardiovascular effect as measured by pulse rate, blood pressure, and symptoms. When these effects do occur, terbutaline sulfate should be discontinued if they occur. The use of terbutaline sulfate should be restricted in patients with cardiovascular disorders, especially coronary insufficiency, arrhythmias, and hypertension.

Seizures

In rare cases, terbutaline sulfate has caused seizures in patients; however, these seizures disappeared once the drug was discontinued.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
+91
  • India (भारत)+91
  • United Arab Emirates (‫الإمارات العربية المتحدة‬‎)+971
  • United States+1
  • China (中国)+86
  • Afghanistan (‫افغانستان‬‎)+93
  • Albania (Shqipëri)+355
  • Algeria (‫الجزائر‬‎)+213
  • American Samoa+1684
  • Andorra+376
  • Angola+244
  • Anguilla+1264
  • Antigua and Barbuda+1268
  • Argentina+54
  • Armenia (Հայաստան)+374
  • Aruba+297
  • Australia+61
  • Austria (Österreich)+43
  • Azerbaijan (Azərbaycan)+994
  • Bahamas+1242
  • Bahrain (‫البحرين‬‎)+973
  • Bangladesh (বাংলাদেশ)+880
  • Barbados+1246
  • Belarus (Беларусь)+375
  • Belgium (België)+32
  • Belize+501
  • Benin (Bénin)+229
  • Bermuda+1441
  • Bhutan (འབྲུག)+975
  • Bolivia+591
  • Bosnia and Herzegovina (Босна и Херцеговина)+387
  • Botswana+267
  • Brazil (Brasil)+55
  • British Indian Ocean Territory+246
  • British Virgin Islands+1284
  • Brunei+673
  • Bulgaria (България)+359
  • Burkina Faso+226
  • Burundi (Uburundi)+257
  • Cambodia (កម្ពុជា)+855
  • Cameroon (Cameroun)+237
  • Canada+1
  • Cape Verde (Kabu Verdi)+238
  • Caribbean Netherlands+599
  • Cayman Islands+1345
  • Central African Republic (République centrafricaine)+236
  • Chad (Tchad)+235
  • Chile+56
  • China (中国)+86
  • Christmas Island+61
  • Cocos (Keeling) Islands+61
  • Colombia+57
  • Comoros (‫جزر القمر‬‎)+269
  • Congo (DRC) (Jamhuri ya Kidemokrasia ya Kongo)+243
  • Congo (Republic) (Congo-Brazzaville)+242
  • Cook Islands+682
  • Costa Rica+506
  • Côte d’Ivoire+225
  • Croatia (Hrvatska)+385
  • Cuba+53
  • Curaçao+599
  • Cyprus (Κύπρος)+357
  • Czech Republic (Česká republika)+420
  • Denmark (Danmark)+45
  • Djibouti+253
  • Dominica+1767
  • Dominican Republic (República Dominicana)+1
  • Ecuador+593
  • Egypt (‫مصر‬‎)+20
  • El Salvador+503
  • Equatorial Guinea (Guinea Ecuatorial)+240
  • Eritrea+291
  • Estonia (Eesti)+372
  • Ethiopia+251
  • Falkland Islands (Islas Malvinas)+500
  • Faroe Islands (Føroyar)+298
  • Fiji+679
  • Finland (Suomi)+358
  • France+33
  • French Guiana (Guyane française)+594
  • French Polynesia (Polynésie française)+689
  • Gabon+241
  • Gambia+220
  • Georgia (საქართველო)+995
  • Germany (Deutschland)+49
  • Ghana (Gaana)+233
  • Gibraltar+350
  • Greece (Ελλάδα)+30
  • Greenland (Kalaallit Nunaat)+299
  • Grenada+1473
  • Guadeloupe+590
  • Guam+1671
  • Guatemala+502
  • Guernsey+44
  • Guinea (Guinée)+224
  • Guinea-Bissau (Guiné Bissau)+245
  • Guyana+592
  • Haiti+509
  • Honduras+504
  • Hong Kong (香港)+852
  • Hungary (Magyarország)+36
  • Iceland (Ísland)+354
  • India (भारत)+91
  • Indonesia+62
  • Iran (‫ایران‬‎)+98
  • Iraq (‫العراق‬‎)+964
  • Ireland+353
  • Isle of Man+44
  • Israel (‫ישראל‬‎)+972
  • Italy (Italia)+39
  • Jamaica+1876
  • Japan (日本)+81
  • Jersey+44
  • Jordan (‫الأردن‬‎)+962
  • Kazakhstan (Казахстан)+7
  • Kenya+254
  • Kiribati+686
  • Kosovo+383
  • Kuwait (‫الكويت‬‎)+965
  • Kyrgyzstan (Кыргызстан)+996
  • Laos (ລາວ)+856
  • Latvia (Latvija)+371
  • Lebanon (‫لبنان‬‎)+961
  • Lesotho+266
  • Liberia+231
  • Libya (‫ليبيا‬‎)+218
  • Liechtenstein+423
  • Lithuania (Lietuva)+370
  • Luxembourg+352
  • Macau (澳門)+853
  • Macedonia (FYROM) (Македонија)+389
  • Madagascar (Madagasikara)+261
  • Malawi+265
  • Malaysia+60
  • Maldives+960
  • Mali+223
  • Malta+356
  • Marshall Islands+692
  • Martinique+596
  • Mauritania (‫موريتانيا‬‎)+222
  • Mauritius (Moris)+230
  • Mayotte+262
  • Mexico (México)+52
  • Micronesia+691
  • Moldova (Republica Moldova)+373
  • Monaco+377
  • Mongolia (Монгол)+976
  • Montenegro (Crna Gora)+382
  • Montserrat+1664
  • Morocco (‫المغرب‬‎)+212
  • Mozambique (Moçambique)+258
  • Myanmar (Burma) (မြန်မာ)+95
  • Namibia (Namibië)+264
  • Nauru+674
  • Nepal (नेपाल)+977
  • Netherlands (Nederland)+31
  • New Caledonia (Nouvelle-Calédonie)+687
  • New Zealand+64
  • Nicaragua+505
  • Niger (Nijar)+227
  • Nigeria+234
  • Niue+683
  • Norfolk Island+672
  • North Korea (조선 민주주의 인민 공화국)+850
  • Northern Mariana Islands+1670
  • Norway (Norge)+47
  • Oman (‫عُمان‬‎)+968
  • Pakistan (‫پاکستان‬‎)+92
  • Palau+680
  • Palestine (‫فلسطين‬‎)+970
  • Panama (Panamá)+507
  • Papua New Guinea+675
  • Paraguay+595
  • Peru (Perú)+51
  • Philippines+63
  • Poland (Polska)+48
  • Portugal+351
  • Puerto Rico+1
  • Qatar (‫قطر‬‎)+974
  • Réunion (La Réunion)+262
  • Romania (România)+40
  • Russia (Россия)+7
  • Rwanda+250
  • Saint Barthélemy+590
  • Saint Helena+290
  • Saint Kitts and Nevis+1869
  • Saint Lucia+1758
  • Saint Martin (Saint-Martin (partie française))+590
  • Saint Pierre and Miquelon (Saint-Pierre-et-Miquelon)+508
  • Saint Vincent and the Grenadines+1784
  • Samoa+685
  • San Marino+378
  • São Tomé and Príncipe (São Tomé e Príncipe)+239
  • Saudi Arabia (‫المملكة العربية السعودية‬‎)+966
  • Senegal (Sénégal)+221
  • Serbia (Србија)+381
  • Seychelles+248
  • Sierra Leone+232
  • Singapore+65
  • Sint Maarten+1721
  • Slovakia (Slovensko)+421
  • Slovenia (Slovenija)+386
  • Solomon Islands+677
  • Somalia (Soomaaliya)+252
  • South Africa+27
  • South Korea (대한민국)+82
  • South Sudan (‫جنوب السودان‬‎)+211
  • Spain (España)+34
  • Sri Lanka (ශ්‍රී ලංකාව)+94
  • Sudan (‫السودان‬‎)+249
  • Suriname+597
  • Svalbard and Jan Mayen+47
  • Swaziland+268
  • Sweden (Sverige)+46
  • Switzerland (Schweiz)+41
  • Syria (‫سوريا‬‎)+963
  • Taiwan (台灣)+886
  • Tajikistan+992
  • Tanzania+255
  • Thailand (ไทย)+66
  • Timor-Leste+670
  • Togo+228
  • Tokelau+690
  • Tonga+676
  • Trinidad and Tobago+1868
  • Tunisia (‫تونس‬‎)+216
  • Turkey (Türkiye)+90
  • Turkmenistan+993
  • Turks and Caicos Islands+1649
  • Tuvalu+688
  • U.S. Virgin Islands+1340
  • Uganda+256
  • Ukraine (Україна)+380
  • United Arab Emirates (‫الإمارات العربية المتحدة‬‎)+971
  • United Kingdom+44
  • United States+1
  • Uruguay+598
  • Uzbekistan (Oʻzbekiston)+998
  • Vanuatu+678
  • Vatican City (Città del Vaticano)+39
  • Venezuela+58
  • Vietnam (Việt Nam)+84
  • Wallis and Futuna (Wallis-et-Futuna)+681
  • Western Sahara (‫الصحراء الغربية‬‎)+212
  • Yemen (‫اليمن‬‎)+967
  • Zambia+260
  • Zimbabwe+263
  • Åland Islands+358
Mobile number

Email

Other Products in 'Active Pharmaceuticals Ingredients (API)' category